The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000508370
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
16/04/2026
Date registered
Help: Date registered
23/04/2026
Date last updated
Help: Date last updated
21/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
23/04/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
The effect of personalised 3D printed metamaterial insoles on plantar pressures in adults at risk of diabetes-related foot wounds.
Scientific title
Evaluation of the effect of 3D printed functionally graded metamaterial insoles on plantar pressures in adults at risk of diabetes-related foot ulceration: A within-subjects crossover study.
Additional trial identifiers [1] 316781 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Related trial records
This is a follow up study to ACTRN 12625000905460. This previous study evaluated the effects of 3D printed functionally graded metamaterial insoles on plantar pressure in healthy adults. Preliminary findings suggest the effects of the insoles on plantar pressure are comparable to the current standard of care insoles in reducing plantar pressures. This follow-up study will evaluate their effect in the target population for the intervention: people at risk of diabetes-related foot ulceration.

Health condition
Health condition(s) studied:
Diabetes-related foot ulceration 341425 0
Peripheral neuropathy 341426 0
Condition category
Condition code
Neurological 337480 337480 0 0
Other neurological disorders
Metabolic and Endocrine 337507 337507 0 0
Diabetes

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Current Australian and international guidelines recommend the use of medical-grade footwear and personalised insoles to prevent diabetes-related foot ulceration in individuals at risk, particularly those with foot deformities or pre-ulcerative lesions.

This study will evaluate whether functionally graded 3D printed insoles that have material stiffness personalised according to plantar pressure measurements are as effective as the current standard of care in reducing plantar pressures in people at risk of diabetes-related foot ulceration.

There are four intervention arms and two control arms. As a randomised immediate effects cross-over study, each participant will experience each intervention and control arm. All intervention arms comprise personalised 3D printed metamaterial insoles with contours designed using 3D scans collected during the initial study appointment, with two also having personalised stiffness based upon plantar pressure data collected at the initial study appointment. Prior engineering work has benchmarked the mechanical properties of the metamaterial structures against materials commonly used in therapeutic insoles, including low-density EVA foam and Poron.

Intervention Arm 1 (Uniform EVA, compression-benchmarked): A 3D printed metamaterial insole with uniform mechanical properties benchmarked to low-density EVA using quasi-static compression testing.

Intervention Arm 2 (Uniform EVA, indenter-benchmarked): A 3D printed metamaterial insole with uniform mechanical properties benchmarked to low-density EVA using localised indenter testing. This arm evaluates an alternative benchmarking methodology that results in a softer metamaterial design than that produced using quasi-static compression benchmarking.

Intervention Arms 3 and 4 (Pressure-personalised designs): Both interventions comprise functionally graded 3D printed metamaterial insoles, with stiffness personalised according to plantar pressure measurements. Regions exposed to lower plantar pressures (less than 50kPa) are assigned firmer mechanical properties, while regions exposed to higher plantar pressures (greater than 200 kPa) are assigned softer mechanical properties. Between these regions, material properties are interpolated to create a graduated transition across the insole. At low pressure regions, both are assigned properties matching low-density EVA using quasi-static compression testing (matching the material of Arm 1).

- Intervention Arm 3: Mechanical properties at high pressure regions are benchmarked to approximate Poron based on quasi-static compression testing.
- Intervention Arm 4: Mechanical properties at high pressure regions are benchmarked to approximate low-density EVA using localised indenter testing (equivalent to the material properties used in Intervention Arm 2).

Participants will be invited to attend two appointments at a QUT research facility. Each appointment is anticipated to take approximately 60 minutes. There will be approximately 2-4 weeks between appointments.

At the initial appointment, following screening for inclusion/exclusion criteria, the participant's feet will be 3D scanned, and in-shoe plantar pressures will be measured while wearing standardised medical grade trial footwear. The 3D scans and plantar pressure data will be used to design insoles used at the second appointment.

At the second appointment, each of the intervention and control insoles will be fitted to the standardised medical grade footwear in a randomised order. The participant will be blinded to the difference between the different insole conditions. Primary outcome measures (plantar pressure in device during gait) will be recorded after a brief period of acclimatisation (at least 2 minutes). The participant will walk straight for approximately 10m at a self-selected speed while data is recorded to provide at least 12 steps of data for the foot. Walking speed during the trial will be self-selected for the first trial and measured, to ensure each subsequent trial is within ten percent of this speed. Trials outside of this will be discarded and repeated to ensure walking speed is kept consistent during testing of each condition. Three trials will be completed for each study arm. There will be a washout and rest period between study arms of at least 3 minutes.

As an immediate effects study design, insoles will not be worn for an extended period nor taken by the participants, and no assessment of adherence will be performed. Should any intervention be discontinued prior to data collection (e.g. due to discomfort reported by participant), this will be reported.

Each intervention and the control insoles will be designed and manufactured by a podiatrist at a QUT research facility. All orthotic devices will be fitted by members of the research team at a QUT research laboratory, under the supervision of a registered podiatrist.
Intervention code [1] 333697 0
Treatment: Devices
Description of the comparator or control
Two control arms will be used in this study:
Control Arm 1 (Reference comparator): standardised medical grade footwear - This represents footwear that meets current guidelines for use by people at risk of diabetes-related foot ulceration with foot deformity and/or pre-ulcerative lesions.
Control Arm 2: Standardised medical grade footwear and current standard of care personalised insole fabricated using standard manufacture means (i.e. CNC milled Ethylene-Vinyl Acetate) to contour the plantar surface of the foot but without personalisation of mechanical properties of the insole i.e. with uniform stiffness. This represents a frequent current practice.
Control group
Active

Outcomes
Primary outcome [1] 344988 0
Peak plantar pressure
Timepoint [1] 344988 0
Immediate effects following a brief acclimatisation period (at least 2 minutes) wearing the insole condition
Secondary outcome [1] 460067 0
Percentage area of foot where peak plantar pressures are reduced by 30% or more or to below 200kPa.
Timepoint [1] 460067 0
Immediate effects following a brief acclimatisation period (at least 2 minutes) wearing the insole condition
Secondary outcome [2] 460068 0
Pressure-time integral
Timepoint [2] 460068 0
Immediate effects following a brief acclimatisation period (at least 2 minutes) wearing the insole condition
Secondary outcome [3] 460069 0
Spatiotemporal parameters of gait
Timepoint [3] 460069 0
This will be measured for each walking trial in each of the trial conditions.
Secondary outcome [4] 460070 0
Comfort in each insole condition
Timepoint [4] 460070 0
Immediately following trials for each insole condition.

Eligibility
Key inclusion criteria
Over 18 years old
Available to attend follow up data collection appointment 2-4 weeks following initial data collection
Able to walk for ten minutes duration without the use of assistive devices (e.g. walking stick or frame)
Diagnosis of diabetes
Have an International Working Group for the Diabetic Foot (IWGDF) risk classification of moderate to high risk with foot deformity or a buildup of hard skin (callous) or a previous history of diabetes related foot ulceration.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Under 18 year of age
Unable to walk for ten minutes unassisted
History of foot or lower limb amputation
History of Charcot neuroarthropathy
Active diabetes-related foot ulceration
End-stage renal disease
History of falls in the past 12 months

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation is not concealed - All participants will experience all intervention arms in this immediate-effects crossover trial.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
The order in which participants will trial each intervention orthosis will be randomised through computer sequence generation.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Efficacy
Statistical methods / analysis
Repeated measures ANOVAs will be used to test the differences between intervention and control arms on plantar pressure outcomes with Bonferroni post-hoc testing used for multiple pairwise comparisons.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
QLD

Funding & Sponsors
Funding source category [1] 321378 0
Government body
Name [1] 321378 0
Australian Department of Health, Disability and Ageing, Medical Research Futures Fund (MRFF)
Country [1] 321378 0
Australia
Primary sponsor type
University
Name
Queensland University of Technology
Address
Country
Australia
Secondary sponsor category [1] 324351 0
None
Name [1] 324351 0
Address [1] 324351 0
Country [1] 324351 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 319918 0
Queensland University of Technology University Human Research Ethics Committee
Ethics committee address [1] 319918 0
Ethics committee country [1] 319918 0
Australia
Date submitted for ethics approval [1] 319918 0
01/12/2025
Approval date [1] 319918 0
26/03/2026
Ethics approval number [1] 319918 0
LR 2026-9938-28794

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 148818 0
Prof Mia Woodruff
Address 148818 0
Biofabrication and Tissue Morphology Group, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 148818 0
Australia
Phone 148818 0
+61 7 31387778
Fax 148818 0
Email 148818 0
Contact person for public queries
Name 148819 0
Hamish Harvey
Address 148819 0
Biofabrication and Tissue Morphology Group, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 148819 0
Australia
Phone 148819 0
+61 7 3138 0296
Fax 148819 0
Email 148819 0
Contact person for scientific queries
Name 148820 0
Hamish Harvey
Address 148820 0
Biofabrication and Tissue Morphology Group, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD, 4059
Country 148820 0
Australia
Phone 148820 0
+61 7 3138 0296
Fax 148820 0
Email 148820 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Data will be made available on QUT's publicly accessible data repository

Conditions for requesting access:
• -

What individual participant data might be shared?
• De-identified individual participant data:
• Published results
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
After publication of main results
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Data repository: Data will be made available on QUT's publicly accessible data repository, via https://data.researchdatafinder.qut.edu.au

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.